| R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction
PLoS ONE, 2016;11(8):e0160153.
Species: Human
Sample Type: Plasma
Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Authors: Jabaudon M, Blondonnet R, Roszyk L, Pereira B, Guerin R, Perbet S, Cayot S, Bouvier D, Blanchon L, Sapin V, Constantin J
PLoS ONE, 2015;10(8):e0135857.
Species: Human
Sample Type: Serum
Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
Authors: Lee A, Lam J, Shiu S, Wong Y, Betteridge D, Tan K
PLoS ONE, 2015;10(9):e0137330.
Species: Human
Sample Type: Serum
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.
Authors: Heier M, Margeirsdottir H, Gaarder M, Stensaeth K, Brunborg C, Torjesen P, Seljeflot I, Hanssen K, Dahl-Jorgensen K
Cardiovasc Diabetol, 2015;14(1):126.
Species: Human
Sample Type: Serum
Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.
Authors: Moser B, Megerle A, Bekos C, Janik S, Szerafin T, Birner P, Schiefer A, Mildner M, Lang I, Skoro-Sajer N, Sadushi-Kolici R, Taghavi S, Klepetko W, Ankersmit H
PLoS ONE, 2014;9(9):e106440.
Species: Human
Sample Type: Serum
The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia.
Authors: Chou C, Lin F, Tsai H, Chang S
BMC Pulm Med, 2014;14(0):182.
Species: Human
Sample Type: BALF
Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study.
Authors: Zakiyanov O, Kriha V, Vachek J, Zima T, Tesar V, Kalousova M
BMC Nephrol, 2013;14(0):245.
Species: Human
Sample Type: Serum
The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
Authors: Brix J, Hollerl F, Kopp H, Schernthaner G, Schernthaner G
Int J Obes (Lond), 2012;36(11):1412-7.
Species: Human
Sample Type: Serum
Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels.
Authors: Campbell D, Somaratne J, Jenkins A, Prior D, Yii M, Kenny J, Newcomb A, Schalkwijk C, Black M, Kelly D
PLoS ONE, 2012;7(11):e49813.
Species: Human
Sample Type: Plasma
Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis.
Authors: Narvaez-Rivera RM, Rendon A, Salinas-Carmona MC
BMC Infect. Dis., 2012;12(0):15.
Species: Human
Sample Type: Serum
Methodological and Preanalytical Evaluation of a RAGE Immunoassay.
Authors: Wittwer C, Lehner J, Fersching D, Siegele B, Stoetzer OJ, Holdenrieder S
Anticancer Res., 2012;32(5):2075-8.
Species: Human
Sample Type: Serum
Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.
Authors: Yamakawa N, Uchida T, Matthay MA, Makita K
Am. J. Physiol. Lung Cell Mol. Physiol., 2011;300(4):L516-25.
Species: Human
Sample Type: pulmonary edema fluid
Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
Authors: Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, Charlton-Menys V, Bao W, Demicco DA, Preston GM, Deshmukh H, Tan K, Fuller JH
Diabetes, 2011;60(9):2379-85.
Species: Human
Sample Type: Serum
Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.
Authors: Jabaudon M, Futier E, Roszyk L
Crit. Care Med., 2011;39(3):480-8.
Species: Human
Sample Type: Plasma
Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
Authors: Nin JW, Jorsal A, Ferreira I
Diabetes, 2010;59(8):2027-32.
Species: Human
Sample Type: Plasma
Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes.
Authors: Tam HL, Shiu SW, Wong Y, Chow WS, Betteridge DJ, Tan KC
Atherosclerosis, 2010;209(1):173-7.
Species: Human
Sample Type: Serum
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy.
Authors: Penfold SA, Coughlan MT, Patel SK
Kidney Int., 2010;78(3):287-95.
Species: Human
Sample Type: Serum
Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.
Authors: Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, Dunn CE, Davies ZA, Moss RB, Herzenberg LA, Herzenberg LA, Tirouvanziam R
Proc. Natl. Acad. Sci. U.S.A., 2009;106(14):5779-83.
Species: Human
Sample Type: Plasma
Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.
Authors: Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB
Am. J. Physiol. Lung Cell Mol. Physiol., 2009;297(6):L1035-41.
Species: Human
Sample Type: Edema Fluid
Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.
Authors: Buhimschi CS, Baumbusch MA, Dulay AT, Oliver EA, Lee S, Zhao G, Bhandari V, Ehrenkranz RA, Weiner CP, Madri JA, Buhimschi IA
Am. J. Pathol., 2009;175(3):958-75.
Species: Human
Sample Type: Plasma
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.
Authors: Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q, Zhang RY, Chen QJ, Shen WF
Atherosclerosis, 2009;205(2):544-8.
Species: Human
Sample Type: Serum
Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
Authors: Mahajan N, Malik N, Bahl A
Atherosclerosis, 2009;207(2):597-602.
Species: Human
Sample Type: Plasma
Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
Acta Neurol. Scand., 2009;120(2):119-22.
Species: Human
Sample Type: Serum
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.
Authors: Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Yasuda T, Umayahara Y, Kosugi K, Yamasaki Y
Atherosclerosis, 2009;204(1):288-92.
Species: Human
Sample Type: Serum
Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia.
Authors: Hallstrom L, Berghall E, Frostell C, Sollevi A, Soop AL
Crit. Care Med., 2008;36(11):3043-7.
Species: Human
Sample Type: Plasma
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
Authors: Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, Sciurba F, Dauber J, Selman M, Gochuico BR, Kaminski N
PLoS Med., 2008;5(4):e93.
Species: Human
Sample Type: Serum
Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.
Authors: Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA,
Thorax, 2008;63(12):1083-9.
Species: Human
Sample Type: Plasma
Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients.
Authors: Gross S, van Ree RM, Oterdoom LH, de Vries AP, van Son WJ, de Jong PE, Navis GJ, Zuurman MW, Bierhaus A, Gans RO, Bakker SJ
Transplantation, 2007;84(5):659-63.
Species: Human
Sample Type: Plasma
|
